Search for: "Gilead Sciences Inc."
Results 121 - 140
of 182
Sort by Relevance
|
Sort by Date
2 Dec 2014, 7:35 am
The judgment is available here on BAILII, and the case is properly called Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Ors [2014] EWHC 3916 (Pat) (01 December 2014).The technical field is treatments for Hepatitis C; the specific area is nucleoside analogues having alleged activity against Hepatitis C Virus and other viruses of the Flaviviridae family. [read post]
17 Nov 2014, 6:50 am
Gilead Sciences, Inc., which is a big reason we cited the horrendous Murthy opinion from a couple years ago, in a case involving clinical trials that left us Dazed and Confused. [read post]
16 Oct 2014, 1:24 am
If you are looking for inhouse counsel jobs, check out some featured postings from our GoInhouse.com job board: Counsel I – Clinical Contracts – Gilead Sciences, Foster City, CA Senior Director, Transactional Counsel – BeachBody, Santa Monica, CA Sr. [read post]
23 Sep 2014, 1:25 pm
The first situation (PTA) was a focus of Gilead Sciences v. [read post]
4 Aug 2014, 9:59 pm
Gilead Sciences, Inc., et al.... [read post]
28 Apr 2014, 9:51 pm
Noonan -- The Federal Circuit extended the scope of the judicially created doctrine of obviousness-type double patenting (OTDP) in a split decision rendered in Gilead Sciences Inc. v. [read post]
27 Apr 2014, 10:00 pm
In Gilead Sciences, Inc. v. [read post]
23 Apr 2014, 6:47 pm
Gilead Sciences, Inc., Rader, CJ Op. at *1. [read post]
22 Apr 2014, 11:51 am
By Dennis Crouch Gilead Sciences v. [read post]
1 Apr 2014, 11:27 am
Gilead Sciences, Inc., 2014 NCBC 10 is a procedural conundrum wrapped up in arbitration issues. [read post]
6 Feb 2014, 11:40 am
Capital Power was represented by a Heenan Blaikie team led by Brian Bidyk.Feb. 8, 2013 – Gilead Sciences, Inc. completes its acquisition of YM BioSciences Inc. [read post]
14 Oct 2013, 11:00 pm
In Gilead Sciences, Inc. v. [read post]
7 Jul 2013, 9:33 am
Usha Rao 2100/DEL/2007 GILEAD SCIENCES,INC. 25(1), Refused Hardev Karar 1135/DEL/2007 GILEAD SCIENCES, INC. 25(1), Refused Hardev Karar 3221/DELNP/2006 IBM Refused M Ravishankar 280/MUM/2005 TATA CHEMICALS LIMITED Refused N. [read post]
3 Mar 2013, 12:06 pm
Patil 1383/MUMNP/2007 GILEAD SCIENCES INC. [read post]
8 Feb 2013, 11:04 am
Gilead Sciences, Inc., v. [read post]
7 Feb 2013, 9:00 am
In Chatham-Kent Wind Action Inc. v. [read post]
14 Jun 2012, 11:55 am
Gilead Sciences is set to climb the most positions within the top 20, moving up seven places to number 15 with prescription sales of $15.1 billion in 2018, thanks in large part to the company’s strong HIV franchise and impressive forecasts for GS-7977, its recently acquired development stage hepatitis C product. [read post]
16 Mar 2012, 2:02 pm
Gilead Sciences, Inc., No. [read post]
16 Mar 2012, 7:23 am
Gilead Sciences, Inc., No. [read post]
16 Mar 2012, 7:23 am
Gilead Sciences, Inc., No. [read post]
